Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-17

Clinical Trial Update: Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035) [Phase 3]

View source ↗

Summary

Phase 3 sulfonylurea add-on study in Type 2 diabetes mellitus completed; results were posted in December 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2010-12-17